The FY2025 (Dec) proxy of Omeros names 12 peer companies for pay. Pay versus performance data of Omeros for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Arcus Biosciences | ||
| Agios Pharmaceuticals | ||
| Vanda Pharmaceuticals | ||
| Aclaris Therapeutics | ||
| Enanta Pharmaceuticals | ||
| Ironwood Pharmaceuticals | ||
| Collegium Pharmaceutical | ||
| Coherus BioSciences, Inc. | Not disclosed | Not disclosed |
| Esperion Therapeutics, Inc. | Not disclosed | Not disclosed |
| Karyopharm Therapeutics Inc. | Not disclosed | Not disclosed |
| Mersana Therapeutics, Inc. | Not disclosed | Not disclosed |
| Pacira BioSciences | Not disclosed | Not disclosed |
12 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.